{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:23:08Z","timestamp":1773706988642,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T00:00:00Z","timestamp":1276992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11255-010-9790-z","type":"journal-article","created":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T20:09:12Z","timestamp":1277064552000},"page":"337-343","source":"Crossref","is-referenced-by-count":26,"title":["Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial"],"prefix":"10.1007","volume":"43","author":[{"given":"Jan","family":"Krhut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Zvara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,20]]},"reference":[{"key":"9790_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00702-007-0862-x","volume":"115","author":"A Apostolidis","year":"2008","unstructured":"Apostolidis A, Fowler CJ (2008) The use of botulinum neurotoxin type A (BoNTA) in urology. J Neural Transm 115:593","journal-title":"J Neural Transm"},{"key":"9790_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","volume":"5","author":"MB Chancellor","year":"2008","unstructured":"Chancellor MB, Fowler CJ, Apostolidis A et al (2008) Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5:319","journal-title":"Nat Clin Pract Urol"},{"key":"9790_CR3","doi-asserted-by":"crossref","unstructured":"Chancellor MB (2009) Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery. Int Urol Nephrol","DOI":"10.1007\/s11255-009-9600-7"},{"key":"9790_CR4","doi-asserted-by":"crossref","unstructured":"Ghalayini IF, Al-Ghazo MA, Elnasser ZA (2009) Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport((R)) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity. Int Urol Nephrol","DOI":"10.1007\/s11255-009-9528-y"},{"key":"9790_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuint.2005.04.021","volume":"47","author":"CP Smith","year":"2005","unstructured":"Smith CP, Vemulakonda VM, Kiss S et al (2005) Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A. Neurochem Int 47:291","journal-title":"Neurochem Int"},{"key":"9790_CR6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuint.2007.11.006","volume":"52","author":"CP Smith","year":"2008","unstructured":"Smith CP, Gangitano DA, Munoz A et al (2008) Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury. Neurochem Int 52:1068","journal-title":"Neurochem Int"},{"issue":"Suppl 1","key":"9790_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","volume":"248","author":"KR Aoki","year":"2001","unstructured":"Aoki KR (2001) Pharmacology and immunology of botulinum toxin serotypes. J Neurol 248(Suppl 1):3","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"9790_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2008.07822.x","volume":"102","author":"MJ Drake","year":"2008","unstructured":"Drake MJ (2008) Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity. BJU Int 102(Suppl 1):11","journal-title":"BJU Int"},{"key":"9790_CR9","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-B","volume":"6","author":"J Jankovic","year":"1997","unstructured":"Jankovic J, Brin MF (1997) Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 6:S129","journal-title":"Muscle Nerve Suppl"},{"key":"9790_CR10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692","journal-title":"J Urol"},{"key":"9790_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11934-002-0081-9","volume":"3","author":"CP Smith","year":"2002","unstructured":"Smith CP, Somogyi GT, Chancellor MB (2002) Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Curr Urol Rep 3:382","journal-title":"Curr Urol Rep"},{"key":"9790_CR12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpuro0672","volume":"4","author":"LA Birder","year":"2007","unstructured":"Birder LA, de Groat WC (2007) Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol 4:46","journal-title":"Nat Clin Pract Urol"},{"key":"9790_CR13","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0022-5347(05)64291-7","volume":"168","author":"OJ Wiseman","year":"2002","unstructured":"Wiseman OJ, Brady CM, Hussain IF et al (2002) The ultrastructure of bladder lamina propria nerves in healthy subjects and patients with detrusor hyperreflexia. J Urol 168:2040","journal-title":"J Urol"},{"key":"9790_CR14","doi-asserted-by":"crossref","first-page":"F966","DOI":"10.1152\/ajprenal.00359.2002","volume":"284","author":"G Apodaca","year":"2003","unstructured":"Apodaca G, Kiss S, Ruiz W et al (2003) Disruption of bladder epithelium barrier function after spinal cord injury. Am J Physiol Renal Physiol 284:F966","journal-title":"Am J Physiol Renal Physiol"},{"key":"9790_CR15","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/S0022-5347(05)64244-9","volume":"168","author":"P Zvara","year":"2002","unstructured":"Zvara P, Kliment J Jr, DeRoss AL et al (2002) Differential expression of bladder neurotrophic factor mRNA in male and female rats after bladder outflow obstruction. J Urol 168:2682","journal-title":"J Urol"},{"key":"9790_CR16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/nau.20020","volume":"23","author":"TL Tan","year":"2004","unstructured":"Tan TL, Bergmann MA, Griffiths D et al (2004) Stop test or pressure-flow study? Measuring detrusor contractility in older females. Neurourol Urodyn 23:184","journal-title":"Neurourol Urodyn"},{"key":"9790_CR17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","volume":"171","author":"CP Smith","year":"2004","unstructured":"Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171:2128","journal-title":"J Urol"},{"key":"9790_CR18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0022-5347(17)41304-8","volume":"141","author":"CB Brendler","year":"1989","unstructured":"Brendler CB, Radebaugh LC, Mohler JL (1989) Topical oxybutynin chloride for relaxation of dysfunctional bladders. J Urol 141:1350","journal-title":"J Urol"},{"key":"9790_CR19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0140-6736(92)91186-C","volume":"339","author":"CJ Fowler","year":"1992","unstructured":"Fowler CJ, Jewkes D, McDonald WI et al (1992) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339:1239","journal-title":"Lancet"},{"key":"9790_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005392-199907000-00002","volume":"162","author":"MB Chancellor","year":"1999","unstructured":"Chancellor MB, de Groat WC (1999) Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 162:3","journal-title":"J Urol"},{"key":"9790_CR21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0022-5347(01)68162-X","volume":"158","author":"D Ridder De","year":"1997","unstructured":"De Ridder D, Chandiramani V, Dasgupta P et al (1997) Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol 158:2087","journal-title":"J Urol"},{"key":"9790_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(02)00072-8","volume":"1","author":"A Szallasi","year":"2002","unstructured":"Szallasi A, Fowler CJ (2002) After a decade of intravesical vanilloid therapy: still more questions than answers. Lancet Neurol 1:167","journal-title":"Lancet Neurol"},{"key":"9790_CR23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","volume":"64","author":"CP Smith","year":"2004","unstructured":"Smith CP, Radziszewski P, Borkowski A et al (2004) Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology 64:871","journal-title":"Urology"},{"key":"9790_CR24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","volume":"49","author":"A Giannantoni","year":"2006","unstructured":"Giannantoni A, Costantini E, Di Stasi SM et al (2006) Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol 49:704","journal-title":"Eur Urol"},{"key":"9790_CR25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC, Yoshimura N, Huang CC et al (2004) Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172:1529","journal-title":"J Urol"},{"key":"9790_CR26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.urology.2004.10.057","volume":"65","author":"H Atiemo","year":"2005","unstructured":"Atiemo H, Wynes J, Chuo J et al (2005) Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model. Urology 65:622","journal-title":"Urology"},{"key":"9790_CR27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A, Popat R, Yiangou Y et al (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174:977","journal-title":"J Urol"},{"key":"9790_CR28","doi-asserted-by":"crossref","first-page":"13396","DOI":"10.1073\/pnas.231243698","volume":"98","author":"LA Birder","year":"2001","unstructured":"Birder LA, Kanai AJ, de Groat WC et al (2001) Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 98:13396","journal-title":"Proc Natl Acad Sci USA"},{"key":"9790_CR29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","volume":"66","author":"M Khera","year":"2005","unstructured":"Khera M, Somogyi GT, Salas NA et al (2005) In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology 66:208","journal-title":"Urology"},{"key":"9790_CR30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4065\/84.8.702","volume":"84","author":"SP Petrou","year":"2009","unstructured":"Petrou SP, Parker AS, Crook JE et al (2009) Botulinum a toxin\/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1\/2 study. Mayo Clin Proc 84:702","journal-title":"Mayo Clin Proc"},{"key":"9790_CR31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","volume":"182","author":"YC Chuang","year":"2009","unstructured":"Chuang YC, Tyagi P, Huang CC et al (2009) Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes. J Urol 182:786","journal-title":"J Urol"},{"key":"9790_CR32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1464-410X.2008.08076.x","volume":"103","author":"A Sahai","year":"2009","unstructured":"Sahai A, Sangster P, Kalsi V et al (2009) Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable? BJU Int 103:630","journal-title":"BJU Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9790-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-010-9790-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9790-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:55:34Z","timestamp":1559375734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-010-9790-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,20]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9790"],"URL":"https:\/\/doi.org\/10.1007\/s11255-010-9790-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,20]]}}}